TN2 brings together fundamental and clinical researchers in the field of Translational Neuroscience from all over the Netherlands and beyond.

Each year the TN2 conference coveres one or several disease indications in either the field of Neurology or of Psychiatry – i.e. in alternating years – thereby providing opportunities for academia and industrial partners to explore new collaborations in plenary sessions, potentially leading to translation of novel disease mechanisms into effective drug therapies, neurotechnologies and disease-monitoring diagnostic tools.

The scientific strategy of Translational Neuroscience is often bidirectional in nature, encompassing both bench-to-bedside factors, which aim to increase the efficiency by which new therapeutic strategies developed through basic research are tested clinically, and bedside-to-bench factors, which provide feedback about the efficacy of the clinical application of new treatments and how they can be improved.